Related Experiment Videos
Monoclonal autoantibodies that react with multiple organs. Basis for reactivity.
Annals of the New York Academy of Sciences
|January 1, 1986
Summary
Monoclonal MOR antibodies are common in both healthy individuals and those with autoimmune diseases. These antibodies are a natural part of the body's B-cell repertoire, suggesting they may be prevalent in most autoantibodies.
Area of Science:
- Immunology
- Autoimmunity
- B-cell biology
Background:
- Monoclonal antibodies are crucial tools in research and therapeutics.
- Autoimmune diseases involve the immune system mistakenly attacking the body's own tissues.
- The origin and prevalence of specific antibody types, like MOR antibodies, require further investigation.
Purpose of the Study:
- To investigate the origin and prevalence of monoclonal MOR antibodies.
- To determine if MOR antibodies are part of the normal B-cell repertoire.
- To explore the potential commonality of MOR antibodies in various populations.
Main Methods:
- Preparation of monoclonal MOR antibodies from mice and humans.
- Utilizing hybridoma technology and Epstein-Barr virus (EBV) transformation of lymphocytes.
- Screening antibody repertoires in both healthy and autoimmune disease cohorts.
Main Results:
- Monoclonal MOR antibodies were successfully generated from diverse sources, including healthy individuals and those with autoimmune conditions.
- MOR antibodies were identified in normal mice and healthy humans, indicating their presence outside of disease states.
- The study demonstrated that MOR antibodies are a common component of the host's natural B-cell repertoire.
Conclusions:
- MOR antibodies are not exclusive to autoimmune diseases and are a common feature of the normal immune system.
- The findings suggest that MOR antibodies may be a frequently encountered type among monoclonal autoantibodies.
- Further research is warranted to fully elucidate the role and implications of MOR antibodies in health and disease.